Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man.
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008099:Liver / Q000187:drug effects; D008297:Male; D010074:Oxandrolone / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010919:Placebos; D014280:Triglycerides; D010074:Oxandrolone; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase